Filing Flows › Apnimed (APMD) › Q2 2026 › vs Q2 2025
Apnimed (APMD) Q2 2026 vs Q2 2025 (year over year)
Apnimed's revenue fell $5.0M (-29%) from $17.1M in Q2 2025 to $12.1M in Q2 2026.
Apnimed, Q2 2026: revenue $12.1M (-29% year over year), operating margin -96.9%, net earnings $126M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $12.1M | $17.1M | −$5.0M | -29% |
| Other income, net | $138M | −$63.5M | $201M | — |
| Costs & expenses | $150M | $86.6M | $63.3M | +73% |
| Operating costs | $23.8M | $23.0M | $738K | +3% |
| Net earnings | $126M | −$69.5M | $195M | — |
| Research & development | $9.9M | $16.0M | −$6.1M | -38% |
| General & admin | $12.7M | $5.4M | $7.3M | +137% |
| Other operating costs | $1.2M | $1.7M | −$514K | -30% |
Questions
How much did Apnimed's revenue grow year over year in Q2 2026?
Apnimed's revenue fell $5.0M (-29%) from $17.1M in Q2 2025 to $12.1M in Q2 2026.